# Characterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC Immunotherapy

> **NCT07668037** · — · RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 600 (estimated)

## Conditions studied

- Non-Small Cell Carcinoma of Lung
- Immunotherapy
- Advanced Non-Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07668037
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2030-05-01
- **Final completion:** 2030-05-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07668037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07668037, "Characterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC Immunotherapy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07668037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*